Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Bringing the Freezing of Biopharmaceuticals in From the Cold
Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing
Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.
View All Featured ArticlesHeadline News
mNEXSPIKE associated with lower COVID-19 hospitalisation risk than Comirnaty in older adults
Spruce separates CRHX-101 programme into new endocrinology company Adrenyx Biosciences
FDA grants Priority Review to BRUKINSA combination in first-line mantle cell lymphoma
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
High-Resolution Characterization of Structure, Interaction, and Miscibility of Drug Products
Presented by Eric Munson, PhD, Professor and Head at Purdue University
11th February 2020
Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted
Presented by Christos Varsakelis, Senior Manager Global Analytics and Innovation, GlaxoSmithKline Biologicals SA, Mark Demesmaeker, Head of Data Analytics at Sartorius Stedim Biotech and Roger-Marc Nicoud, President & CEO Ypso-Facto
10th March 2021
Biopharmaceutical process development – Trends/ Challenges/Opportunities
Presented by Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd and Sudhakar Nagaraj, Principal Scientist, SLS – Global Regulatory and Validation Consulting group at Pall Biotech
20th November 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Strategy Emerging Markets for Risk Mitigation
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















